BIOR insider transaction filings

BIORA THERAPEUTICS, INC. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-12-16. Screen BIOR transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for BIOR between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.

Recent Form 4 filings — BIORA THERAPEUTICS, INC.

FiledFormInsiderReported transactionsSource
2024-12-164Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner
Athyrium Opportunities III Acquisition LP — Director, 10% owner
Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner
Athyrium Opportunities 2020 LP — Director, 10% owner
Ferrell Jeffrey — Director, 10% owner
Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner
Athyrium Funds GP Holdings LLC — Director, 10% owner
Athyrium Opportunities Associates III LP — Director, 10% owner
Athyrium Opportunities Associates III GP LLC — Director, 10% owner
Grant/award (A)EDGAR
2024-08-164MOHANTY ADITYA P. — Chief Executive Officer, DirectorTax withholding (F): 70,883 @ $0.67EDGAR
2024-08-164dEsparbes Eric — Chief Financial OfficerTax withholding (F): 27,830 @ $0.67EDGAR
2024-08-164NEUMANN CLARKE — See RemarksTax withholding (F): 26,629 @ $0.67EDGAR
2024-08-144Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner
Athyrium Opportunities III Acquisition LP — Director, 10% owner
Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner
Athyrium Opportunities 2020 LP — Director, 10% owner
Ferrell Jeffrey — Director, 10% owner
Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner
Athyrium Funds GP Holdings LLC — Director, 10% owner
Athyrium Opportunities Associates III LP — Director, 10% owner
Athyrium Opportunities Associates III GP LLC — Director, 10% owner
Disposition to issuer (D) · Grant/award (A) · Disposition to issuer (D): 323,886 (derivative) · Grant/award (A): 323,886 (derivative) · Disposition to issuer (D): 500,249 (derivative) · Grant/award (A): 500,249 (derivative) · +6 moreEDGAR
2024-07-084Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner
Athyrium Opportunities III Acquisition LP — Director, 10% owner
Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner
Athyrium Opportunities 2020 LP — Director, 10% owner
Ferrell Jeffrey — Director, 10% owner
Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner
Athyrium Funds GP Holdings LLC — Director, 10% owner
Athyrium Opportunities Associates III LP — Director, 10% owner
Athyrium Opportunities Associates III GP LLC — Director, 10% owner
Grant/award (A): 457,250 (derivative)EDGAR
2024-07-054Athyrium Opportunities III Co-Invest 1 LP — Director, 10% owner
Athyrium Opportunities III Acquisition LP — Director, 10% owner
Athyrium Opportunities III Acquisition 2 LP — Director, 10% owner
Athyrium Opportunities 2020 LP — Director, 10% owner
Ferrell Jeffrey — Director, 10% owner
Athyrium Opportunities Associates Co-Invest LLC — Director, 10% owner
Athyrium Funds GP Holdings LLC — Director, 10% owner
Athyrium Opportunities Associates III LP — Director, 10% owner
Athyrium Opportunities Associates III GP LLC — Director, 10% owner
Grant/award (A)EDGAR
2024-06-064Powell Lynne — DirectorGrant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-06-064Howe Jill Ann — DirectorGrant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-06-064Kotzin Brian L. — DirectorGrant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-06-064Alter Jeffrey D. — DirectorGrant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR

Recent 8-K events — BIORA THERAPEUTICS, INC.

FiledFormItems reportedSource
2024-12-308-K1.01 — Entry into a Material Definitive Agreement
1.03 — Bankruptcy or Receivership
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-108-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-158-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-298-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-118-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-078-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
EDGAR
2024-09-138-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
EDGAR
2024-09-058-K8.01 — Other EventsEDGAR
2024-08-218-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →